Medverita Lactobacillus gasseri 3 Billion CFU 120 Capsules

The dietary supplement Medverita Lactobacillus gasseri 3 Billion CFU 120 Capsules is a probiotic and prebiotic product containing Lactobacillus gasseri LGS06 bacteria and acacia fibers that are encapsulated in a vegan capsule.

The live bacterial cultures in probiotic form help restore the physiological number of microorganisms living in the digestive tract, e.g., after taking an antibiotic that may have reduced their population. The presence of bacteria in the gut is extremely important as they aid digestion by producing enzymes, including cellulase, which enables the breakdown of cellulose into simple sugars. They also cause fermentation of the digestive contents and regulate intestinal activity. Furthermore, they produce vitamins such as biotin and menaquinone (vitamin K2). It is often forgotten that the gut microbiota also has a stimulating effect on the immune system by helping to combat pathogenic microorganisms.

In the Medverita supplement, we find 3 billion bacteria of the Lactobacillus gasseri strain LGS06 per capsule. It is important to know that the interesting interior of the capsule must pass through the highly acidic environment of the stomach to reach the intestine intact. To prevent the freeze-dried bacteria from being damaged by stomach acid, they are encapsulated in a lipid matrix that makes them resistant to its effects.

In addition to the gut bacteria, the product contains acacia fiber from Acacia Senegal. It is a water-soluble compound that is not absorbed in the intestine. It is a prebiotic, meaning a substance that the bacteria in the digestive tract feed on.

In summary, Medverita Lactobacillus gasseri 3 Billion CFU 120 Capsules is a dietary supplement with live bacterial cultures that are encapsulated in a convenient vegan capsule. Thanks to its content of acacia fiber, it acts both as a probiotic and a prebiotic.

1 Wieërs G, Belkhir L, Enaud R, Leclercq S, Philippart de Foy JM, Dequenne I, de Timary P, Cani PD. How probiotics influence the microbiota. Front Cell Infect Microbiol. 2020 Jan 15;9:454. doi: 10.3389/fcimb.2019.00454. PMID: 32010640; PMCID: PMC6974441.

2 Trafalska E, Grzybowska K. Probiotics--alternatives to antibiotics? . Wiad Lek. 2004;57(9-10):491-8. Polish. PMID: 15765768.